ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "dendritic cells and systemic lupus erythematosus (SLE)"

  • Abstract Number: 2978 • 2017 ACR/ARHP Annual Meeting

    OX40/OX40L Axis Impairs Follicular and Natural Regulatory T Cell Function in Human Systemic Lupus

    Christophe Richez1, Jean-Francois Augusto2, Clement Jacquemin3, Estibaliz Lazaro4, Marie-Elise Truchetet1, Noémie Gensous5, Isabelle Douchet5, Thierry Schaeverbeke6, Cécile Contin-Bordes7 and Patrick Blanco7, 1Department of Rheumatology, Bordeaux University Hospital, Bordeaux, France, 2Department of Nephrology, Angers University Hospital, Angers, France, 3Université de Bordeaux, Bordeaux, France, 4Department of Internal Medecine and Clinical Immunology, Bordeaux University Hospital, Pessac, France, 5UMR CNRS 5164, Bordeaux, France, 6Department of Rheumatology, Bordeaux University Hospital, BORDEAUX, France, 7Immunology, Department of Immunology, Bordeaux University Hospital, Bordeaux, France

    Background/Purpose: Regulatory T cells (Treg) are impaired in human Systemic Lupus Erythematosus (SLE) and contribute to T cell activation. However, the mechanisms responsible for the…
  • Abstract Number: 2323 • 2012 ACR/ARHP Annual Meeting

    A Genetic Polymorphism on New Zealand Black Chromosome 1 Is Associated with Abnormal Dendritic Cell Function Leading to Expansion of TH1, TH17 and T Follicular Helper (TFH) Cells

    Nafiseh Talaei1, Carolina Landolt-Marticorena2, Babak Noamani1, Evelyn Pau3, Nan-Hua Chang4 and Joan E. Wither5, 1Genetics and developmental biology, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2Rheumatology, University Health Network, Toronto, ON, Canada, 3Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 4Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 51E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: We have previously shown that B6 mice with an introgressed homozygous New Zealand Black chromosome (c) 1 interval (70 to 100 cM) develop high titres…
  • Abstract Number: 2679 • 2012 ACR/ARHP Annual Meeting

    Loss of Caspase 8 in Dendritic Cells Induces a Systemic Lupus Erythematosus-Like Disease That Is Independent of the Necroptosome

    Carla M. Cuda1, Alexander V. Misharin2, Rana Saber2, G. Kenneth Haines III3, Jack Hutcheson4, Chandra Mohan5 and Harris R. Perlman6, 1Medicine / Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University, Chicago, IL, 3Department of Pathology, Yale University, New Haven, CT, 4Internal Medicine - Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX, 5Internal Medicine/Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, 6Feinberg School of Medicine, Northwestern University, Chicago, IL

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multi-organ, destructive autoimmune disease characterized by pathogenic autoantibodies.  Though it is accepted that dendritic cells (DCs) play an…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology